关于甲胺潜在抗作用的新见解:机制性途径
Saud A Alnaaim1, Hayder M Al-Kuraishy2, Ali I Al-Gareeb2
1Clinical Neurosciences Department, College of Medicine, King Faisal University, Hofuf, Saudi Arabia.
Journal of cellular and molecular medicine
|September 22, 2023
概括
甲福明是一种抗糖尿病药物,通过调节关键细胞通路,表现出抗发作活性. 这篇评论探讨了它的机制,表明它有可能作为耐火性的补充疗法.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 影响全球数以百万计的人,其中很大一部分患有耐药性.
- 传统的抗药物 (AEA) 在30%-40%的患者中是无效的,增加了风险.
- 探索新的治疗标和附加剂对于治疗耐火性至关重要.
研究的目的:
- 阐明甲胺在中的机械作用.
- 审查甲福明的抗发作活性及其潜在的分子通路.
- 评估甲福明作为耐火性的辅助疗法的潜力.
主要方法:
- 对甲福明抗效应的临床前和临床研究的综述.
- 对甲福明对细胞信号通路 (AMPK,mTOR) 的影响的分析.
- 检查甲福明对神经营养因子 (BDNF) 和其他蛋白质 (progranulin,α-synuclein) 的影响.
主要成果:
- 甲胺激活AMPK并抑制mTOR通路,这些通路与有关.
- 甲福明增强了来自大脑的神经营养因子 (BDNF) 的表达,从而赋予神经保护.
- 甲福明通过降低α-synuclein和增加蛋白酸酶2A (PPA2) 来调节神经炎症.
结论:
- 甲胺通过多种分子机制表现出抗发作特性.
- 甲胺的神经保护和抗炎作用有助于其抗的潜力.
- 甲福明可以作为耐药性患者的宝贵辅助疗法,需要进一步调查.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
223
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
223
Antiepileptic Drugs: GABAergic Pathway Potentiators
446
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
446
Antiepileptic Drugs: Glutamate Antagonists
407
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
407
Antiepileptic Drugs: Potassium Channel Activators
203
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
203
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
332
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
332
Electron Transport Chain: Complex I and II
14.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.3K


